Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts - New Market Report


Print article Print article
2013-12-14 10:07:19 - Recently published research from GlobalData, "MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts", is now available at Fast Market Research

Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the heart's electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to moderate cases, patients with more severe conditions must turn to device use or surgical intervention in order to receive the therapy they require. Over the years, CRM device treatment has become less invasive, and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.

Full Report Details at
- www.fastmr.com/prod/752871_medipoint_cardiac_rhythm_management_a ..

Across the three countries included in

this report, there is a marked heterogeneity in the pacemaker implantation rate per million inhabitants. Moreover, there is also a large gap among the countries in the number of pacemaker-implanting centers per million inhabitants.

Scope

* An overview of hypertension, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
* Annualized APAC CRM market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
* Investigation of current and future market competition for CRM
* Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
* Competitor assessment including device approval analysis and device sales forecasts.
* Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
* Analysis of unmet needs within the market and opportunities for future players.
* Technology trends evaluation to assess strength of pipeline.
* An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
* Company profiles including business description, financial overview and SWOT analysis.
* Coverage of key market players.
* Strategic assessment of the CRM sector through market impact analysis, future market scenario and company analysis.
* Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists

Reasons to Get this Report

* Understand the trends shaping and driving APAC CRM market.
* Realize device preferences of physicians who have performed the tests already.
* Access market sizing, forecasts and quantified growth opportunities in APAC CRM market through 2018.
* Quantify candidate patient populations to better design product pricing & launch plans.
* Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
* Perform benchmarking analysis of growth opportunities against currently marketed products.
* Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
* Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
* Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
* Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
* What's the next big thing in APAC CRM market landscape? Identify, understand and capitalize.

Companies Mentioned in this Report: Biotronik, Boston Scientific, Impulse Dynamics, Medtronic, Sorin Group, St. Jude Medical

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Disease Overview
3.1 Anatomy and Physiology
3.1.1 Risk Factors
3.1.2 Etiology
3.2 Pathophysiology
3.2.1 Cardiac Arrhythmias
3.3 Clinical Presentation
3.3.1 Symptoms
3.4 Diagnosis
3.4.1 Blood and Urine Diagnostic Procedures
3.4.2 Electrocardiography-Based Diagnostic Procedures
3.4.3 Computerized Tomographic Angiography
3.4.4 Electrophysiological Testing
3.4.5 Electromechanical Wave Imaging
3.4.6 Echocardiography
3.4.7 Tilt-Table Testing
3.4.8 Diagnostic and Electrophysiological Studies
3.4.9 New York Heart Association Scale
3.4.10 American College of Cardiology Scale
3.4.11 Level of Evidence
3.5 Epidemiology
3.5.1 Prevalence
4 Industry Overview
4.1 Overview
4.2 Clinical Outcomes
4.2.1 Pacemakers
4.2.2 ICDs
4.2.3 CRT-Ps
4.2.4 CRT-Ds
4.3 Procedure Trends
4.3.1 Single-Chamber Devices More Popular than Dual-Chamber Devices in Developing Economies
4.3.2 Cardiac Resynchronization Therapy Increasingly Popular Around the World
4.3.3 Device Reuse Programs to Transform Currently Wasted Resource
4.3.4 Hospital Market Growth
4.4 Market Access
4.4.1 Asia-Pacific
4.4.2 Reimbursement Trends
4.5 Regulatory Issues/Recalls
4.5.1 Medtronic Pacemakers Recalled over Failure Risk, 2009
4.5.2 St. Jude Riata ICD Leads Recalled, 2011
4.6 Mergers and Acquisitions
4.6.1 Boston Scientific Acquires C.R. Bard's Electrophysiology Business
4.6.2 Sorin Group Closes Further Investment and Option-to-Buy in Enopace Biomedical
4.7 Key Partnerships
4.7.1 Leti Forms Partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII IC
4.7.2 St. Jude Medical to Invest in Nanostim
4.7.3 Sorin Group Signs Supply Agreement for Boston Scientific Corporation Lotus Valve System
4.8 Economic Impact
4.8.1 Cost-Effectiveness of Pacemakers
4.8.2 Cost-Effectiveness of ICDs
4.8.3 Cost-Effectiveness of Cardiac Resynchronization Therapy
4.9 Market Drivers
4.9.1 Rapidly Increasing Patient Populations Suitable for Device Implantation to Drive Sales
4.9.2 Technological Advances and New Products in Pipeline to Drive Sales

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=752871&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com